NBIX NEUROCRINE BIOSCIENCES INC: institutional ownership and insider trading
820 funds reported holding $18.8B of NEUROCRINE BIOSCIENCES INC in their latest 13F filings; in Q2 2026 funds net bought $183M, with 146 new positions and 64 funds selling out; over the last 12 months insiders bought $0 and sold $77.0M on the open market.
Famous investors holding NBIX
- Renaissance Technologies (Renaissance Technologies): $394M, 0.5% of the portfolio
- Two Sigma (Two Sigma Investments): $350M, 0.3% of the portfolio
- Ray Dalio (Bridgewater Associates): $34.7M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $12.2M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.95M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $944K, 0.0% of the portfolio
Largest institutional holders of NBIX
- BlackRock, Inc. (BLK) — $2.31B
- VANGUARD GROUP INC — $1.38B
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $1.09B
- DODGE & COX — $941M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $838M
- VANGUARD CAPITAL MANAGEMENT LLC — $766M
- STATE STREET CORP (STT, STT-PG) — $739M
- AQR CAPITAL MANAGEMENT LLC — $643M
- RENAISSANCE TECHNOLOGIES LLC — $394M
- GEODE CAPITAL MANAGEMENT, LLC — $360M
Recent NBIX insider trades
- Sep 14, 2026: Abernethy Matt sold 2,311 shares ($363K)
- Sep 14, 2026: Boyer David W. sold 826 shares ($130K)
- Sep 9, 2026: Benevich Eric sold 2,154 shares ($333K)
- Jul 28, 2026: Norwalk Leslie V sold 1,250 shares ($228K)
Members of Congress trading NBIX
- Jun 17, 2025: Lisa C. McClain sold part of $1.00K–$15.0K
- Jun 11, 2025: Lisa C. McClain bought $1.00K–$15.0K
5%+ owners
- Vanguard Capital Management: 5.2% (Schedule 13G, filed Apr 30, 2026)
- JPMORGAN CHASE & CO.: 5.2% (Schedule 13G/A, filed Oct 15, 2026)